NK cells from Men Who Have Sex with Men at high risk for HIV-1 infection exhibit higher effector capacity

被引:0
作者
Rincon, Daniel S. [1 ,2 ]
Florez-Alvarez, Lizdany [1 ,2 ]
Taborda, Natalia A. [3 ]
Hernandez, Juan C. [2 ]
Rugeles, Maria T. [1 ]
Zapata-Builes, Wildeman [1 ,2 ]
机构
[1] Univ Antioquia UdeA, Fac Med, Grp Inmunovirol, Medellin 050010, Colombia
[2] Univ Cooperat Colombia, Fac Med, Grp Infettare, Medellin 050016, Colombia
[3] Corp Univ Remington, Medellin 050012, Colombia
关键词
EXPOSED SERONEGATIVE SUBJECTS; NATURAL-KILLER-CELLS; EXPRESSION; PROTECTION; INDIVIDUALS; PARTNERS; NKG2D;
D O I
10.1038/s41598-023-44054-1
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Despite being under constant exposure to HIV-1, some individuals do not show serological or clinical evidence of infection and are known as HESN (HIV-Exposed Seronegative). Multiple studies in different HESN cohorts have linked the NK cells as a correlate of resistance; however, little is known about the role of these cells in Men Who Have Sex with Men (MSM) with high risk sexual behaviors. We evaluated a general overview of activation and effector features of NK cells of MSM co-cultured with LT CD4(+) HIV+ in which MSM at high risk of HIV-1 infection (HR-MSM) exhibit higher capacity to eliminate infected cells, reduced percentages of CD69(+) cells when compared to MSM at low risk of infection (LR-MSM). In addition, we found that, despite the lower levels of CD69(+) NK cells on HR-MSM group, within this population, higher percentages of CD69(+) IFN-gamma (+) and CD69(+) NKG2D(+) NK cells were found together with higher levels of RANTES and Granzyme B production with higher antiviral capacity, resulting in a lower concentration of p24 protein and p24(+) CD4(+) T cells. Altogether, this information suggests that NK cells of MSM could impact the capacity to face the viral infection.
引用
收藏
页数:13
相关论文
共 40 条
[21]  
Kokuina E, 2019, MEDICC REV, V21, P16, DOI 10.37757/MR2019.V21.N2-3.5
[22]   Distinct Natural Killer Cells in HIV-Exposed Seronegative Subjects With Effector Cytotoxic CD56dim and CD56bright Cells and Memory-Like CD57+NKG2C+CD56dim Cells [J].
Lima, Josenilson F. ;
Oliveira, Luanda M. S. ;
Pereira, Natalli Z. ;
Mitsunari, Gabrielle E. ;
Duarte, Alberto J. S. ;
Sato, Maria N. .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2014, 67 (05) :463-471
[23]   Breast milk cellular HIV-specific interferon γ responses are associated with protection from peripartum HIV transmission [J].
Lohman-Payne, Barbara ;
Slyker, Jennifer A. ;
Moore, Stephen ;
Maleche-Obimbo, Elizabeth ;
Wamalwa, Dalton C. ;
Richardson, Barbra A. ;
Rowland-Jones, Sarah ;
Mbori-Ngacha, Dorothy ;
Farquhar, Carey ;
Overbaugh, Julie ;
John-Stewart, Grace .
AIDS, 2012, 26 (16) :2007-2016
[24]  
Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845
[25]   Natural killer cells in HIV-1 infection and therapy [J].
Mikulak, Joanna ;
Oriolo, Ferdinando ;
Zaghi, Elisa ;
Di Vito, Clara ;
Mavilio, Domenico .
AIDS, 2017, 31 (17) :2317-2330
[26]   Host immune Responses in Hiv-1 infection: The emerging Pathogenic Role of Siglecs and Their Clinical Correlates [J].
Mikulak, Joanna ;
Di Vito, Clara ;
Zaghi, Elisa ;
Mavilio, Domenico .
FRONTIERS IN IMMUNOLOGY, 2017, 8
[27]   The 'immunologic advantage' of HIV-exposed seronegative individuals [J].
Miyazawa, Masaaki ;
Lopalco, Lucia ;
Mazzotta, Francesco ;
Lo Caputo, Sergio ;
Veas, Francisco ;
Clerici, Mario .
AIDS, 2009, 23 (02) :161-175
[28]   Increased IFN-γ production by NK and CD3+/CD56+ cells in sexually HIV-1-exposed but uninfected individuals [J].
Montoya, Carlos Julio ;
Velilla, Paula Andrea ;
Chougnet, Claire ;
Landay, Alan L. ;
Rugeles, Maria Teresa .
CLINICAL IMMUNOLOGY, 2006, 120 (02) :138-146
[29]   Effects of HIV infection and ART on phenotype and function of circulating monocytes, natural killer, and innate lymphoid cells [J].
Nabatanzi, Rose ;
Cose, Stephen ;
Joloba, Moses ;
Jones, Sarah Rowland ;
Nakanjako, Damalie .
AIDS RESEARCH AND THERAPY, 2018, 15
[30]  
Pende D, 2001, EUR J IMMUNOL, V31, P1076, DOI 10.1002/1521-4141(200104)31:4<1076::AID-IMMU1076>3.0.CO